Sarcopenia & anabolic resistance

Sarcopenia is the clinical name for the muscle loss that accelerates after middle age — but the more useful question is why the training and protein that built muscle at 25 produce slower results at 45. The answer sits in two places: the muscle's structure changes, and its molecular response to stimulation changes. Both turn out to be more fixable than they look.

What Sarcopenia Actually Is

Sarcopenia is the progressive loss of muscle mass, strength, and function with age. The 2019 European consensus definition (EWGSOP2) makes low muscle strength the entry criterion, with low muscle mass or quality confirming the diagnosis — a deliberate choice, because strength predicts disability and death better than size does. In community-dwelling adults, roughly 5–13% of people in their 60s and 70s meet criteria, rising to 11–50% past 80 (von Haehling et al., 2010). The US healthcare costs attributable to sarcopenia were estimated at about $18.5 billion per year (Janssen et al., 2004). But the honest framing is simpler: sarcopenia is the clinical label for a process every untrained adult is undergoing. This page is about the biology underneath it.

The schedule matters more than the totals. The loss is silent for decades because human function carries slack — you don't notice a shrinking reserve until a task approaches its ceiling. The parent topic runs the decade-by-decade timetable; the point here is that by the time stairs feel different, much of the reserve is already spent.

The Three Biological Shifts

• 🧵 Type II fibers shrink first. Muscle biopsies across the lifespan show fast-twitch (type II) fibers losing size preferentially while slow-twitch (type I) fibers hold up — in 70-year-olds, type II fibers are roughly a quarter smaller than in young adults (Nilwik et al., 2013). Earlier work showed fiber number also drops, again favoring type II loss (Lexell et al., 1988). Fast fibers generate quick force; their decline explains the power gap and part of the fall risk.
• 🫧 Strength outruns mass — the quality problem. In the Health ABC cohort, knee-extensor strength declined about three times faster than lean mass over three years (Goodpaster et al., 2006). Meanwhile fat infiltrates the muscle itself, even in adults whose weight stays stable (Delmonico et al., 2009). The gap between "looking fine" and "being fine" widens quietly.
• 🔌 The nervous system ages too. Motor neurons are lost with age; surviving motor units reinnervate the orphaned fibers, producing larger but slower, less precisely controlled units. Some of the "muscle" decline is really a control-system decline — one reason coordination and balance erode alongside raw strength.

None of these three shifts is purely inevitable. Each carries a large disuse component, which is why the fourth section of this page matters most.

Anabolic Resistance: The Door Opens Less

Anabolic resistance is the finding that the same anabolic stimulus produces a smaller protein-synthesis response in older muscle. The term emerged from work showing blunted signaling inside elderly muscle after amino acid feeding (Cuthbertson et al., 2005). Two numbers anchor it. In one study, 20 grams of whey protein after resistance exercise stimulated muscle protein synthesis robustly in young men but produced a muted response in older men — as if the dose were smaller (Kumar et al., 2009). In another, maximizing the post-meal response required about 0.4 g of protein per kg of body weight in older adults versus 0.24 g/kg in young — roughly two-thirds more (Moore et al., 2015). A higher proportion of leucine appears to be needed to trigger the response at all (Katsanos et al., 2006).

This is not destiny. A single bout of resistance exercise re-sensitizes older muscle to protein for about a day afterward (Burd et al., 2013) — training is the direct counterweight to anabolic resistance. That is precisely why the minimum effective dose page matters: the training you are already doing is what keeps the door open.

Disuse Is the Multiplier

Biology sets the slope; disuse picks the speed. In a study of healthy adults around age 67, just ten days of bed rest cost roughly a kilogram of leg lean mass and a double-digit percentage of knee-extensor strength (Kortebein et al., 2007). Older adults lose muscle during inactivity faster than young adults do and regain it more slowly — a single hospital stay or a few weeks of injury rest can erase months of training. The uncomfortable arithmetic: after 40, total inactivity is never neutral. The encouraging corollary is that the opposite is true as well — modest, consistent training measurably slows every one of the three biological shifts above.

The Insulin Connection

Muscle is the body's largest glucose sink, taking up most of the glucose from a meal — skeletal muscle insulin resistance is widely regarded as the primary defect in type 2 diabetes (DeFronzo & Tripathy, 2009). Less muscle means a smaller sink and higher post-meal glucose. The epidemiology agrees: in NHANES III, greater muscle mass relative to height was inversely associated with insulin resistance and prediabetes across more than 13,000 adults (Srikanthan & Karlamangla, 2011). The relationship runs both ways — insulin signaling is itself anabolic for muscle, so metabolic dysfunction accelerates sarcopenia in a loop. The insulin resistance page runs the glucose story; body composition covers the muscle-versus-fat framing. The short version here: sarcopenia and metabolic decline are not separate problems of aging — they are two ends of the same rope.

Slower, Not Absent: The Response at Every Age

The landmark demonstration remains the Fiatarone study: ten nursing-home residents with a mean age of 90, most using walkers, performed eight weeks of high-intensity leg-press training and grew stronger by about 174% on average — some left their walkers behind (Fiatarone et al., 1990). Since then, meta-analyses of resistance training in healthy older adults have repeatedly found relative strength gains comparable to those of young adults (Borde et al., 2015). What changes with age is the starting point and the pace — not the capacity to adapt. Sarcopenia is better understood as untrained aging muscle than as an untreatable condition.

Questions, Answered Briefly

• 🍗 Do I need more protein than the RDA? The 0.8 g/kg RDA is a floor for sedentary adults. Older adults who train generally do better at 1.2–1.6 g/kg or more — the Nutrition pillar covers the evidence and the distribution across meals.
• 🧪 Should I measure my muscle? DEXA quantifies lean mass if you want a baseline, but the cheapest useful proxy is grip strength — it tracks function better than size does.
• ⏳ When does this actually start? The biology starts in your 30s; the functional consequences usually announce themselves in your 50s and 60s. The case for training is strongest before the announcement.
• 💊 Is there a drug for this? Investigational compounds targeting muscle signaling exist in early-stage research, but none has displaced training and protein as the intervention with actual evidence behind it.

Related Topics